Incyte's crown jewel is a drug called Jakafi, which treats several conditions, including myelofibrosis, which is a form of bone marrow cancer.Incyte recently announced that it was initiating a phase 3 clinical trial to study the safety and efficacy of Jakafi as a potential treatment for COVID-19 in patients 12 years and older.